Central roles of GABA,glutamic acid decarboxylase (GAD) activity and mRNA GAD expression in the regulation of blood pressured and vasopressin release in sportaneous hypertensive rats (SHR)
Central roles of GABA,glutamic acid decarboxylase (GAD) activity and mRNA GAD expression in the regulation of blood pressured and vasopressin release in sportaneous hypertensive rats (SHR)
批准号:
07457162
负责人:
KIMURA Tokihisa
金额:
$4.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
It is known that central amino acid (AA) plays important roles in the regulation of blood pressure and hormonal release. GABA suppresses a neural activity and glutamate (GLU) activates it. Thus, it is likely that the distortion of these AA release may affect the central regulation of blood pressure (BP) and vasopressin (AVP) release, thereby leading to hypertension.In the present study, in order to investigate central roles of AA in the development of hypertension in SHR,GABA and GLU release adjacent to the paraventricular nucleus were determined using a microdialysis method under osmotic and hemorrhagic stimuli in conscious SHR and normotensive rats (WKY), and BP and AVP release were also determined. Moreover, central changes in a glutamic acid decarboxylase (GAD) activity and GAD mRNA expression were determined in SHR and WKY.In intravenous administration of 2.5M NaCl, increases in plasma AVP levels and BP in SHR were greater than their increases in WKY,but central GABA release in SHR was smaller than it in WKY.GLU decreased in SHR and WKY.In hemorrhagic decreases in BP to the same extent, plasma AVP in SHR increased greater than it in WKY,but GABA and GLU decreased. There were no differences in them in SHR and WKY.A GAD activity and mRNA GAD expression in 11 week-old SHR were smaller than them in 11 week-old WKY.In conclusion, decreases in a GAD activity, its expression and GABA release might be related to the development of hypertension and enhanced AVP release in SHR.
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
木村 時久: "尿崩症治療薬" 臨床医. 21. 452-456 (1995)
Tokihisa Kimura:“尿崩症的治疗药物”临床医生。21. 452-456 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
木村 時久: "浮腫・胸・腹水の治療" 疾患別 最新処方. 618-619 (1995)
木村时久:“水肿、胸腹水的治疗”最新处方618-619(1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
木村 時久: "脱水症" 疾患別 最新処方. 616-617 (1995)
Tokihisa Kimura:“脱水”每种疾病的最新处方616-617(1995)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
木村 時久: "Vasopressin antagonistの臨床応用" Annual Review 内分泌代謝1996. 45-50 (1996)
木村时久:《加压素拮抗剂的临床应用》年度评论内分泌代谢 1996. 45-50 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
木村 時久: "Anion gapとは" Medical Practice. (in press).
Tokihisa Kimura:“什么是负离子间隙?”(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 52 条
Effects of interleukin-1beta on the release of AVP, ANP, and ACTH, cardiovascular function and thermogenesis.
-
批准号:04454260
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.46万
-
财政年份:1992
-
负责人:KIMURA Tokihisa
-
依托单位:
The Central Effects of Gabanergic Neurons on Cardiovascular Function and Body Fluid Regulation.
-
批准号:01570463
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1989
-
负责人:KIMURA Tokihisa
-
依托单位:
The central or peripheral effects of atrial natriuretic peptide on the renin-angiotensin-aldosterone system, vasopressin release, and renal functions.
-
批准号:60570380
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1985
-
负责人:KIMURA Tokihisa
-
依托单位:
国内基金
海外基金
登录
查看更多内容
石斛有效成分毛兰素靶向GGT7-GSH/Glutamate信号轴增强索拉非尼诱导的铁死亡逆转肝癌索拉非尼耐药的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:陈鹏
-
依托单位:
孕激素通过下丘脑Glutamate信号通路抑制LH峰的机制研究
-
批准号:82001502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:刘亚丽
-
依托单位:
BF区GABA-Glutamate-Ach神经微环路在麻醉-觉醒调控中的作用机制研究
-
批准号:81571351
-
项目类别:面上项目
-
资助金额:67.0万元
-
批准年份:2015
-
负责人:董海龙
-
依托单位:
穴位埋线调节围绝经期惊恐障碍患者脑神经活动Glutamate-GABA机制的在体研究
-
批准号:81473755
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2014
-
负责人:陈贵珍
-
依托单位: